Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 697

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 697
---
 ​ | ​ | ​                                  | ​ |   9,308 | ​ | ​ | ​ | ​                                      | ​ | *     | ​ | ​ |
| Joana Goncalves, M.D.(10)                                                | ​ | ​ | ​                                  | ​ |   4,447 | ​ | ​ | ​ | ​                                      | ​ | *     | ​ | ​ |
| All current executive officers and directors as a group (8 persons)﻿(11) | ​ | ​ | ​                                  | ​ | 201,954 | ​ | ​ | ​ | ​                                      | ​ | 4.3%  | ​ | ​ |

* Represents beneficial ownership of less than 1%. (1) Based solely on Schedule 13D filed by Vifor (International) Ltd. and CSL Limited on October 30, 2024. Vifor (International) Ltd. and CSL Limited have shared voting power and dispositive power as to all of the shares. The address of Vifor (International) Ltd. is Rechenstrasse 37 CH-9014, St. Gallen Switzerland. The address of CSL Limited is 655 Elizabeth Street, Melbourne VIC, 3000 (AU). (2) Consists of 10,025 shares held directly by Mr. Posner, 1,822 RSUs that vest within 60 days of January 15, 2025 and 61,766 shares of common stock underlying options that are vested and exercisable within 60 days of January 15, 2025. (3) Consists of 667 shares held directly by Mr. Maynard and 15,092 shares of common stock underlying options that are vested and exercisable within 60 days of January 15, 2025. (4) Consists of 6,799 shares held directly by Mr. Terrillion, 555 RSUs that vest within 60 days of January 15, 2025 and 32,524 shares of common stock underlying options that are vested and exercisable within 60 days of January 15, 2025. (5) Consists of 9,143 shares held directly by Mr. Vogelbaum and 19,800 shares of common stock underlying options that are vested and exercisable within 60 days of January 15, 2025. (6) Consists of 6,489 shares of common stock underlying options that are vested and exercisable within 60 days of January